Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CandeSpartan Study Candesartan Spanish Response-prediction and Tolerability Study Observational Study on Response Predictors and Tolerability of Candesartan in Usual Clinical Practice

NCT04138316 is registered in ClinicalTrials.gov with Hospital Clínico Universitario de Valladolid as lead sponsor.

NCT NCT04138316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CandeSpartan Study Candesartan Spanish Response-prediction and Tolerability Study Observational Study on Response Predictors and Tolerability of Candesartan in Usual Clinical Practice
Lead sponsor
Hospital Clínico Universitario de Valladolid
Phase
Observational
Overall status
Completed
Start date
January 2, 2020
Completion date
December 16, 2022
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head pain, migraine